After making nearly $550 million worth of acquisitions in the past few years, the medical device contract manufacturer will ...

Medtronic's US$90.03 share price signals that it might be 33% undervalued ...

Across medtech, companies have continued to innovate through the first nine months of 2024, and that rings especially true in ...

Dunn Brothers Coffee, the Minneapolis-based nearly 40-year-old brand famed for freshly roasting its globally sourced single-origin green beans daily in its coffee shops, announced its official ...

Dr. Jeffrey Popma, the chief medical officer for the Structural Heart business unit at Medtronic, plans to retire, company ...

Two of the top 10 largest medtech companies will partner together on robotic head and spine procedures, with Medtronic ...

Vice presidential candidates Ohio Senator J.D. Vance and Minnesota Governor Tim Walz met on the debate stage at CBS Broadcast ...

"The world needs more leaders like Lisa," said Ashley McEvoy, who also discussed diversity in medtech and what's next for her ...

Medtronic leaned into its robotics and navigation strategy during the third quarter of 2024. Here are four things to know: 1. On the heels of a strong start for Medtronic's fiscal year 2025, CEO Geoff ...

The Weekender gets a little crazy with National Mad Hatter Day to bring you the best in weekend fun. Check out the list of ...

Analyst Josh Jennings from TD Cowen maintained a Buy rating on Medtronic (MDT – Research Report) and keeping the price target at $95.00.

At its current valuation, DexCom stock is the opposite of a bargain. Even after its big drop over the summer, it would still be a risky stock to buy now. Those who are interested would probably do ...